Acorn Cardiovascular Will Try Again for FDA Approval of Device

The fourth time may be the charm for Acorn Cardiovascular. At least that's what Rich Lunsford, CEO of the med-tech firm whose "heart sock" device has already suffered three major regulatory setbacks, is hoping for.

>>> Discuss This Story